基本信息
浏览量:122
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Richard Williams has worked at the Kennedy Institute of Rheumatology since 1989 and was a Senior Lecturer (2007-2011) and then Reader (2011-2012) at Imperial College London before joining the University of Oxford.
He is also a Visiting Lecturer at Queen Mary University of London and the London School of Hygiene and Tropical Medicine and was recently appointed as an Editor of Frontiers in Immunology.
He has established an internationally recognised reputation in translational research and his early studies were instrumental in the development of TNF blocking biologics.
He has carried out numerous projects with British and overseas industrial partners, including Merck, Pfizer, GSK, UCB, Schering, Celgene and J&J and has led an MRC DPFS project on rheumatoid arthritis.
He is also a Visiting Lecturer at Queen Mary University of London and the London School of Hygiene and Tropical Medicine and was recently appointed as an Editor of Frontiers in Immunology.
He has established an internationally recognised reputation in translational research and his early studies were instrumental in the development of TNF blocking biologics.
He has carried out numerous projects with British and overseas industrial partners, including Merck, Pfizer, GSK, UCB, Schering, Celgene and J&J and has led an MRC DPFS project on rheumatoid arthritis.
研究兴趣
论文共 373 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Best Practice & Research Clinical Rheumatologypp.101941-101941, (2024)
Maarten Swart,Andia Redpath,Joy Ogbechi,Ryan Cardenas,Louise Topping, Ewoud B. Compeer, Michael Goddard,Anastasios Chanalaris,Richard Williams,Daniel S. Brewer,Nicola Smart,Claudia Monaco,
biorxiv(2024)
Cancersno. 11 (2023): 2895-2895
Journal of Autoimmunity (2023): 103031-103031
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn